Advertisement
Giving docetaxel at the same time as hormone therapy can improve survival for men with newly diagnosed

ASCO: Docetaxel With Hormone Tx May Improve Outcomes

0
Combination with hormone therapy can extend life by almost a year for prostate cancer patients
For patients with refractory metastatic colorectal cancer

TAS-102 Ups Overall Survival in Refractory Metastatic CRC

0
Most frequently observed clinically significant adverse events include neutropenia, leukopenia
Paying smokers to quit seems to work better than offering them free counseling and nicotine replacement therapy

Financial Incentives Effective in Smoking Cessation

0
Found to be better alternative than free counseling, cessation aids
A form of vitamin B3 (nicotinamide) is linked to a reduction of non-melanoma skin cancers by 23 percent when taken twice daily

ASCO: Nicotinamide May Help Prevent Non-Melanoma Skin CA

0
Preliminary Australian study saw association between nicotinamide and lower rates
An antibiotics-first approach could be considered for specific patients with appendicitis

Study Considers Antibiotics-First Approach to Appendicitis

0
Case vignette presents issues related to immediate appendectomy versus antibiotics-first
There was a sharp rise in the number of emergency department visits involving tramadol between 2005 and 2011

Tramadol-Related ER Visits Up 2005 to 2011

0
U.S. report found problem was greatest among women and patients 55 and older
Males benefit indirectly when girls are immunized against human papillomavirus

HPV Vaccination of Females Has Some Indirect Benefit for Males

0
Strongest effect on penile cancer; smallest effect on anal cancer
Tetanus

No Adverse Pregnancy Outcomes for Tdap at 32 Weeks

0
Preterm birth, incidence of SGA, length of neonatal hospitalization up for women declining vaccine
For children with viral acute respiratory tract infection

Positive + Negative Treatment Recs Cut Antibiotic Rx

0
Findings among children presenting to providers with viral acute respiratory tract infection
Men undergoing androgen-deprivation therapy to treat prostate cancer may experience impaired cognitive function within the first six months that persists for at least a year

ADT for Prostate Cancer Tied to Impaired Cognition

0
Men with a particular gene mutation affected most, researchers find